Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Greenberg

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|June 1, 1982
Inhibition of Escherichia coli heat-stable enterotoxin effects on intestinal guanylate cyclase and fluid secretion by quinacrineR N Greenberg, R L Guerrant, B Chang, et al.
Clinical Therapeutics|January 1, 1987
Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulationR N Greenberg, P M Reilly, W J Weinandt, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patientsG W Elmer, L V McFarland, C M Surawicz, et al.
The American Journal of Physiology|August 5, 1998
Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidneyM C Fonteles, R N Greenberg, H S Monteiro, et al.
Critical Care Medicine|June 1, 1992
Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsisR N Greenberg, K M Wilson, A Y Kunz, et al.
Regulatory Peptides|July 26, 2002
Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestineS L Carrithers, B A Jackson, W Y Cai, et al.
Progress in Clinical and Biological Research|January 1, 1991
Randomized, double-blind phase II study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infectionsR N Greenberg, K M Wilson, A Y Kunz, et al.
Infection Control and Hospital Epidemiology|February 2, 1999
Recurrent Clostridium difficile disease: epidemiology and clinical characteristicsL V McFarland, C M Surawicz, M Rubin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgeryR E Condon, A P Walker, C B Hanna, et al.
Infection and Immunity|December 1, 1984
Effects of Escherichia coli heat-stable enterotoxin STb on intestines of mice, rats, rabbits, and pigletsD J Kennedy, R N Greenberg, J A Dunn, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|June 1, 1982
Inhibition of Escherichia coli heat-stable enterotoxin effects on intestinal guanylate cyclase and fluid secretion by quinacrineR N Greenberg, R L Guerrant, B Chang, et al.
Clinical Therapeutics|January 1, 1987
Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulationR N Greenberg, P M Reilly, W J Weinandt, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patientsG W Elmer, L V McFarland, C M Surawicz, et al.
The American Journal of Physiology|August 5, 1998
Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidneyM C Fonteles, R N Greenberg, H S Monteiro, et al.
Critical Care Medicine|June 1, 1992
Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsisR N Greenberg, K M Wilson, A Y Kunz, et al.
Regulatory Peptides|July 26, 2002
Site-specific effects of dietary salt intake on guanylin and uroguanylin mRNA expression in rat intestineS L Carrithers, B A Jackson, W Y Cai, et al.
Progress in Clinical and Biological Research|January 1, 1991
Randomized, double-blind phase II study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infectionsR N Greenberg, K M Wilson, A Y Kunz, et al.
Infection Control and Hospital Epidemiology|February 2, 1999
Recurrent Clostridium difficile disease: epidemiology and clinical characteristicsL V McFarland, C M Surawicz, M Rubin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgeryR E Condon, A P Walker, C B Hanna, et al.
Infection and Immunity|December 1, 1984
Effects of Escherichia coli heat-stable enterotoxin STb on intestines of mice, rats, rabbits, and pigletsD J Kennedy, R N Greenberg, J A Dunn, et al.
Pageof 10